Otitis Media Clinical Trial
— SIUTITOfficial title:
The Effects of Ventilation Tubes Versus no Ventilation Tubes for Recurrent Acute Otitis Media or Chronic Otitis Media With Effusion in 9 to 36 Month Old Greenlandic Children - a Randomised Clinical Trial
Verified date | November 2020 |
Source | Zealand University Hospital |
Contact | n/a |
Is FDA regulated | No |
Health authority | |
Study type | Interventional |
The prevalence of otitis media among Greenlandic children is one of the highest in the world and twenty per cent of schoolchildren have impaired hearing in the frequencies for normal speech. Yet, there are no national guidelines to ensure prevention and treatment of recurrent acute otitis media and chronic otitis media with effusion and impaired hearing in Greenlandic children. International studies from the developed part of the world have shown that otitis prone children may benefit from tubulation of the tympanic membrane. However, it is unknown if these results can be applied to Greenlandic children. This PhD project will conduct a randomised controlled trial comparing tubulation of the tympanic membrane, in Greenlandic children aged 9-36 months with recurrent acute otitis media and/or chronic otitis media with effusion, to conservative treatment. The children will be followed for two years. Outcome measures will include number of visits to health clinics, number of tympanic membrane perforations, number of episodes with acute otitis media according to medical records, Quality of life, measured by the validated questionnaires OM6 and Caregiver Impact Questionnaire, number of episodes where per oral or intravenous antibiotics have been administered according to medical records and serious adverse events The trial will be conducted in collaboration with the Greenlandic health authorities and Copenhagen Trial Unit. With this trial the investigators hope to decrease the number of episodes with acute otitis media, the number of Greenlandic children with chronic perforations of the tympanic membrane and hearing impairment and increase quality of life. The results will add important knowledge to the effect of ventilation tube treatment also in an international aspect. There are to date only less than a handful of high quality studies concerning this issue on an international basis. The study will be among the first addressing this problem among populations with high risk of otitis media and is also of interest to other indigenous populations and the developing part of the world.
Status | Terminated |
Enrollment | 31 |
Est. completion date | November 2, 2020 |
Est. primary completion date | November 2, 2020 |
Accepts healthy volunteers | No |
Gender | All |
Age group | 9 Months to 36 Months |
Eligibility | Inclusion criteria: - Children aged 9-36 months. - Children with at least one Greenlandic born parent with at least one Greenlandic born parent - American Society of Anaesthesiologists physical status classification class 1 and 2 - B- or C2 - type curve measured by tympanometry at two visits three-four months apart or three episodes of acute otitis media in six months according to medical records or four episodes of acute otitis media in 12 months according to medical records - Signed informed consent, signed by the legal guardian Exclusion criteria - Children with orofacial cleft, Downs syndrome or known generalised immune deficiency - American Society of Anaesthesiologists physical status classification class > 2. - Lack of signed informed consent, signed by the legal guardian. Description of experimental and control intervention Experimental intervention: The intervention group will be treated with bilateral Donaldson ventilation tubes administered in general anaesthesia Control intervention: The control intervention is based on the current practice in Greenland, which includes systemic antibiotic treatment as well as aural toilette and topical antibiotics. Ventilation tube insertion during the study period is not accepted in the control group. Children in the intervention group as well as the control group will be seen once a year by the visiting ear-nose-and throat (ENT)-specialist and have a final consultation after at least two years after randomisation. |
Country | Name | City | State |
---|---|---|---|
Greenland | Aasiaat Regional Hospital | Aasiaat | Danmark |
Greenland | Ilulissat Regional Hospital | Ilulissat | Danmark |
Greenland | Nuuk Health Center | Nuuk | Danmark |
Greenland | Qaqortoq Regional Hospital | Qaqortoq | |
Greenland | Sisimiut Regional Hospital | Sisimiut | Danmark |
Greenland | Tasiilaq Health Center | Tasiilaq | Danmark |
Lead Sponsor | Collaborator |
---|---|
Zealand University Hospital | Copenhagen Trial Unit, Center for Clinical Intervention Research, Government of Greenland, Agency for Health and Prevention |
Greenland,
Type | Measure | Description | Time frame | Safety issue |
---|---|---|---|---|
Other | Number of episodes of aural discharge | According to medical records | Two years after randomisation | |
Other | Serious adverse events | Any adverse event that results in death, is life-threatening, requires hospitalisation or prolongation of existing hospitalisation, or results in persistent or significant disability or incapacity. | During the trial | |
Primary | Number of visits to health clinic | Assessed by investigating medical records. | Two years after randomisation | |
Secondary | Number of episodes of acute otitis media | According to medical records | Two years after randomisation | |
Secondary | Quality of life | Measured by validated questionnaires OM6 and Caregiver Impact Questionnaire | Assessed at baseline, three months after randomisation, one year after randomisation, and at the end of the trial two years after randomisation | |
Secondary | Number of episodes where per oral or intravenous antibiotics have been administered | According to medical records | Two years after randomisation | |
Secondary | Proportion of children with uni- or bilateral tympanic membrane perforations | Based on otoscopical photos, which will be anonymised and evaluated by an ENT-specialist without knowledge of the intervention | Two years after randomisation |
Status | Clinical Trial | Phase | |
---|---|---|---|
Completed |
NCT04016051 -
Acceptance of Clarithromycin in a Straw Compared to Syrup in Children With Upper Respiratory Tract Infections
|
Phase 3 | |
Completed |
NCT02452164 -
Family MobilePhone Otoscopy in Diagnostics of Otitis Media
|
N/A | |
Completed |
NCT01199016 -
Effect of Prevnar 13 on Ear Infections in Children
|
Phase 4 | |
Terminated |
NCT00778063 -
Study Using Dexmedetomidine to Decreases Emergence Delirium in Pediatric Patients
|
N/A | |
Completed |
NCT00195611 -
Study of Streptococcus Pneumoniae in Nose and Throats of Infants With Acute Otitis Media
|
Phase 4 | |
Recruiting |
NCT03722160 -
Clinical Study of the Solo Tympanostomy Tube Device
|
N/A | |
Recruiting |
NCT04447521 -
Surveillance of Non-invasive Streptococcus Pneumoniae Infections in Belgium
|
||
Active, not recruiting |
NCT05127161 -
Broad Implementation of Outpatient Stewardship
|
N/A | |
Completed |
NCT02600559 -
Open-Label Study of OTO-201 in Pediatric Subjects With a History of Otitis Media Requiring Tympanostomy Tubes
|
Phase 3 | |
Completed |
NCT01444391 -
inVENT-visIOn Study
|
N/A | |
Enrolling by invitation |
NCT01437436 -
The Effect of Obesity on Ventilation Tube Insertion
|
N/A | |
Completed |
NCT01003210 -
Homeopathic Ear Drops for Otitis Media Study
|
N/A | |
Completed |
NCT00768534 -
Study Evaluating Microbiological Analysis of Spontaneous Draining Acute Otitis Media
|
N/A | |
Recruiting |
NCT00393159 -
The Influence of The Ear Popper on Serous Otitis Media and on the Accompanying Conductive Hearing Loss in Children
|
Phase 4 | |
Completed |
NCT00617682 -
Maternal Immunization To Prevent Infant Otitis Media
|
Phase 1/Phase 2 | |
Withdrawn |
NCT00956748 -
N-Acetylcysteine as an Adjunct for Refractory Chronic Suppurative Otitis Media
|
Phase 4 | |
Withdrawn |
NCT01908764 -
Pharmacokinetic Study of AL-60371 Otic Suspension in Pediatric Subjects Following Tympanostomy Tube Surgery
|
Phase 1 | |
Recruiting |
NCT01619462 -
Safety and Immunogenicity of 10-valent and 13-valent Pneumococcal Conjugate Vaccines in Papua New Guinean Children
|
Phase 3 | |
Completed |
NCT02616458 -
The Impact of Ear Pain Anticipatory Guidance Counseling on Otitis Related Visits in a Low Income Population
|
N/A | |
Completed |
NCT00051753 -
Levofloxacin In The Treatment Of Children With Recurrent And/or Persistent Acute Otitis Media
|
Phase 3 |